Novo Nordisk stock posts worst week since 2021, but analysts see a bigger problem ahead

Invezz

Published

Novo Nordisk stock sharply tanked this week, marking the pharmaceutical company’s worst-ever weekly loss with a decline of more than 30% by Friday. This plunge extended the stock to its lowest point since August 2021, erasing nearly all gains made since the launch of its blockbuster weight-loss drug Wegovy. Not long ago, the company was […]

Full Article